“…The C. elegans WBC pathway uses all of the positively acting core components of a canonical Wnt pathway (Wnt, Fz, Dsh, b-catenin, and TCF) except for LRP, and the homologs of the b-catenin destruction complex components (PRY-1/Axin, GSK-3/GSK3b, APR-1/ APC, and KIN-19/CK1a) function as negative regulators of this pathway (Eisenmann 2005;Gleason et al 2006). For example, in pry-1/ Axin mutants, several Wnt-responsive Hox genes (lin-39, mab-1, and egl-5) are expressed outside their normal domains and mutant animals display phenotypes consistent with over-or ectopic activation of the Wnt pathway (Harris et al 1996;Eisenmann et al 1998;Maloof et al 1999;Gleason et al 2002Gleason et al , 2006Howard and Sundaram 2002;Korswagen et al 2002;Oosterveen et al 2007). PRY-1 physically interacts with APR-1, GSK-3, and BAR-1 , presumably to phosphorylate BAR-1, which contains eight GSK-3 consensus phosphorylation sites (Eisenmann et al 1998).…”